EPISODE · Feb 18, 2026 · 57 MIN
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
from Hematologic Oncology Update
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.CME information and select publications here.
NOW PLAYING
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
No transcript for this episode yet
Similar Episodes
May 27, 2026 ·21m
May 9, 2026 ·18m
Apr 21, 2026 ·9m
Apr 10, 2026 ·42m
Mar 28, 2026 ·24m